
ABBVIE INC.
ABBV
![]() |
|
150USD | -0.38% |
Turn to zoom
Prev. | 150.0000 |
Open | 149.5200 |
High | 150.0500 |
Low | 147.7500 |
Volume | 8 403 429 |
Latest news
Chart ABBVIE INC.
Technical analysis trends
Short Term | Mid-Term | Long Term | |
Trend | Neutral | Neutral | Bullish |
Resistance | 162 | 175 | 175 |
Spread/Res. | -8,6% | -15% | -15% |
Spread/Supp. | 0,97% | 29% | 9,1% |
Support | 147 | 115 | 136 |
Financials
|
|
Company
AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohnâ'Ts disease, thyroid disease, Parkinsonâ'Ts disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with...
>> Read more
>> Read more
Sector : |
Other Pharmaceuticals
|
Calendar : |
2022-06-01 Presentation
|
Trading Rating : |
Investor Rating : |
Income Statement Evolution
Consensus
Sell ![]() Buy |
|
Mean consensus | OUTPERFORM |
Number of Analysts | 25 |
Last Close Price | 150,57 $ |
Average target price | 164,23 $ |
Spread / Average Target | 9,07% |